-
-
-
-
-
-
-
Cytosorbents (CTSO) Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR
-
-
-
-
-
-
-
Cytosorbents (CTSO) Tops Q4 EPS by 2c, Misses on Revenue
-
-
-
-
-
-
-
Cytosorbents (CTSO) and Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India
-
-
-
-
-
-
-
Cytosorbents (CTSO) Regains Nasdaq Compliance
-
-
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

